Swiss National Bank’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-2,739
| Closed | -$484K | – | 2668 |
|
2023
Q1 | $484K | Sell |
2,739
-322
| -11% | -$56.9K | ﹤0.01% | 2532 |
|
2022
Q4 | $1.18M | Buy |
3,061
+61
| +2% | +$23.6K | ﹤0.01% | 2256 |
|
2022
Q3 | $1.01M | Buy |
3,000
+53
| +2% | +$17.9K | ﹤0.01% | 2333 |
|
2022
Q2 | $969K | Buy |
2,947
+139
| +5% | +$45.7K | ﹤0.01% | 2386 |
|
2022
Q1 | $1.23M | Buy |
2,808
+364
| +15% | +$159K | ﹤0.01% | 2307 |
|
2021
Q4 | $1.07M | Hold |
2,444
| – | – | ﹤0.01% | 2440 |
|
2021
Q3 | $1.36M | Hold |
2,444
| – | – | ﹤0.01% | 2276 |
|
2021
Q2 | $1.26M | Sell |
2,444
-562
| -19% | -$289K | ﹤0.01% | 2370 |
|
2021
Q1 | $2.35M | Buy |
3,006
+206
| +7% | +$161K | ﹤0.01% | 1907 |
|
2020
Q4 | $1.53M | Hold |
2,800
| – | – | ﹤0.01% | 2066 |
|
2020
Q3 | $1.28M | Buy |
2,800
+50
| +2% | +$22.9K | ﹤0.01% | 1944 |
|
2020
Q2 | $1.69M | Buy |
2,750
+486
| +21% | +$299K | ﹤0.01% | 1806 |
|
2020
Q1 | $1.08M | Buy |
2,264
+36
| +2% | +$17.1K | ﹤0.01% | 1790 |
|
2019
Q4 | $1.29M | Buy |
2,228
+103
| +5% | +$59.7K | ﹤0.01% | 1991 |
|
2019
Q3 | $1.4M | Buy |
2,125
+292
| +16% | +$192K | ﹤0.01% | 1873 |
|
2019
Q2 | $1.42M | Buy |
1,833
+136
| +8% | +$105K | ﹤0.01% | 1917 |
|
2019
Q1 | $1.2M | Buy |
1,697
+55
| +3% | +$38.9K | ﹤0.01% | 1973 |
|
2018
Q4 | $768K | Buy |
1,642
+84
| +5% | +$39.3K | ﹤0.01% | 2146 |
|
2018
Q3 | $1.34M | Buy |
1,558
+233
| +18% | +$201K | ﹤0.01% | 1975 |
|
2018
Q2 | $913K | Hold |
1,325
| – | – | ﹤0.01% | 2223 |
|
2018
Q1 | $591K | Buy |
1,325
+150
| +13% | +$66.9K | ﹤0.01% | 2323 |
|
2017
Q4 | $518K | Hold |
1,175
| – | – | ﹤0.01% | 2401 |
|
2017
Q3 | $579K | Hold |
1,175
| – | – | ﹤0.01% | 2333 |
|
2017
Q2 | $651K | Buy |
+1,175
| New | +$651K | ﹤0.01% | 2318 |
|
2016
Q2 | – | Sell |
-836
| Closed | -$182K | – | 2610 |
|
2016
Q1 | $182K | Buy |
836
+139
| +20% | +$30.3K | ﹤0.01% | 2567 |
|
2015
Q4 | $423K | Buy |
+697
| New | +$423K | ﹤0.01% | 2354 |
|